1. Home
  2. OPHC vs PYPD Comparison

OPHC vs PYPD Comparison

Compare OPHC & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OptimumBank Holdings Inc.

OPHC

OptimumBank Holdings Inc.

N/A

Current Price

$9.11

Market Cap

110.1M

Sector

Finance

ML Signal

N/A

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

N/A

Current Price

$5.42

Market Cap

107.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OPHC
PYPD
Founded
2000
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.1M
107.0M
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
OPHC
PYPD
Price
$9.11
$5.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$10.92
★ $11.40
AVG Volume (30 Days)
57.3K
★ 108.8K
Earning Date
11-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.48
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.08
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.92
$3.50
52 Week High
$10.68
$5.84

Technical Indicators

Market Signals
Indicator
OPHC
PYPD
Relative Strength Index (RSI) 54.60 56.18
Support Level $8.48 $4.18
Resistance Level $9.26 $5.58
Average True Range (ATR) 0.38 0.28
MACD 0.04 0.05
Stochastic Oscillator 67.16 68.29

Price Performance

Historical Comparison
OPHC
PYPD

About OPHC OptimumBank Holdings Inc.

OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. The services provided by the bank include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, borrowings, repayment of loans, money market deposit accounts, debit cards, automated teller machines, and other bank related services.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: